Susquehanna Fundamental Investments’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$127K Sell
816
-176
-18% -$27.4K ﹤0.01% 1437
2021
Q4
$295K Sell
992
-44
-4% -$13.1K 0.01% 1123
2021
Q3
$597K Buy
+1,036
New +$597K 0.01% 1115
2021
Q1
Sell
-1,016
Closed -$898K 1638
2020
Q4
$898K Sell
1,016
-217
-18% -$192K 0.02% 902
2020
Q3
$780K Buy
+1,233
New +$780K 0.02% 729